↑ 薬物リストへ　← 戻る

Non propietry, therefore n/a    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
51全身性強皮症1

51. 全身性強皮症　［臨床試験数：466，薬物数：536（DrugBank：142），標的遺伝子数：110，標的パスウェイ数：210］
Searched query = "Scleroderma", "Systemic sclerosis", "SSc", "dcSSc", "lcSSc"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 466 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2004-002799-41-GB
(EUCTR)		15/08/200729/06/2005Iontophoresis as a possible therapy for digital ischaemia - preliminary studies in patients with scleroderma spectrum disorders - Vasodilator iontophoresis as a possible therapy for digital ischaemiaIontophoresis as a possible therapy for digital ischaemia - preliminary studies in patients with scleroderma spectrum disorders - Vasodilator iontophoresis as a possible therapy for digital ischaemia Digital ischaemia/ulceration in patients with scleroderma-spectrum disordersTrade Name: NON PROPIETRY, THEREFORE N/A
Product Name: SODIUM NITROPRUSSIDE		Salford Royal Hospitals TrustUNIVERSITY OF MANCHESTERNot RecruitingFemale: yes
Male: yes		6Phase 2United Kingdom